CBS News Staffers on the Verge of Revolt If This Person Is Hired
As Puerto Ricans Call for Independence Their Dreams Are Blocked By Their Chief...
President Trump Closes the Overton Window
The Fake Stream Media’s Pervasive Assault on Black America
Mamdani: More Continuation Than Aberration for New York
President Trump Is Bringing the Spirit of Sports Back to America
Money, Power and Transgender Ideology
Cleaning Up the Swamp Is a Full-Time Job for Trump
Iran's Mullahs Staring Into the Abyss
The Party of Losers Is Not Funny
The Enduring Lie of Socialism
DOJ: Minnesota Duo Orchestrated Kidnappings, Bombings in Africa
Michigan Woman Indicted for Smuggling Illegal Aliens, Children, Across the Northern Border
Tennessee Joins 25-State Coalition Defending Second Amendment Rights for Travelers
DOD Calls Out 'Highly Provocative' Move by Venezuela
Tipsheet

'Revolving Door': What the WH Left Out of Its Announcement About Nominee for NIH Director

President Biden on Monday nominated Dr. Monica Bertagnolli, a surgical oncologist and head of the National Cancer Institute, to be the next director of the National Institutes of Health, but critics say the White House left out an important detail about her background in the administration’s announcement.  

Advertisement

“Dr. Bertagnolli has spent her career pioneering scientific discovery and pushing the boundaries of what is possible to improve cancer prevention and treatment for patients, and ensuring that patients in every community have access to quality care,” Biden said in a statement.
 
“As Director of the National Cancer Institute, Dr. Bertagnolli has advanced my Cancer Moonshot to end cancer as we know it. She has brought together partners and resources from different sectors to launch groundbreaking efforts in cancer prevention and early detection, a national navigation program for childhood cancers, and additional programs to bring clinical trials to more Americans,” the statement continued. “Dr. Bertagnolli is a world-class physician-scientist whose vision and leadership will ensure NIH continues to be an engine of innovation to improve the health of the American people.” 

As Democratic presidential candidate Robert F. Kennedy Jr. and others pointed out, she’s a “revolving door” nominee. 

“From 2015-2021, Bertagnolli received more than 116 grants from Pfizer, totaling $290.8 million. This amount made up 89% of all her. research grants,” he tweeted. 

Kennedy was sure to point out this doesn’t automatically make her “personally corrupt,” but that she will champion Big Pharma’s viewpoints.  

Advertisement

“That is how agencies are captured,” he added, commenting later that he was not surprised the White House left this detail out of the announcement. 


Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement